Research Article

Del nido kardiyoplejisinin izole erişkin koroner baypas cerrahisinde metabolik etkisi: Retrospektif karşılaştırmalı bir çalışma

Volume: 65 Number: 1 March 9, 2026
EN TR

Del nido kardiyoplejisinin izole erişkin koroner baypas cerrahisinde metabolik etkisi: Retrospektif karşılaştırmalı bir çalışma

Abstract

Aim: Del Nido cardioplegia (DNK), initially developed for pediatric cardiac surgery, has recently been applied to adult cardiac surgery. This study retrospectively compared the effects of Del Nido and conventional blood cardioplegia on intraoperative arterial lactate levels and the need for inotropic agents after cardiopulmonary bypass (CPB) in adult patients undergoing isolated elective coronary artery bypass surgery (CABG). Materials and Methods: A retrospective analysis of 1,286 patients who underwent isolated elective CABG at Mersin City Training and Research Hospital between January 2021 and December 2024 was conducted. Based on the inclusion and exclusion criteria, 574 patients were included in the study. These patients were divided into two groups based on the type of cardioplegia administered: Group 1 – DNK (n=287) and Group 2 – conventional blood cardioplegia (n=287). DNK was prepared as a 4:1 blood-crystalloid mixture and administered in a single dose, while conventional cardioplegia was administered in multiple doses. Arterial blood gas samples were taken before KPB (T0), 5 minutes (T1), 20 minutes (T2), 40 minutes (T3), and 10 minutes after weaning from CPB (T4). Lactate levels were compared; preoperative ejection fraction (EF), KPB and cross-clamp times, and post-KPB inotrope requirements were analyzed. Results: There were no significant differences between the groups in terms of age, gender, preoperative EF, KPB duration, and cross-clamp times (p>0.05). Lactate levels were similar at T0, T1, and T2 (p>0.05). However, mean lactate levels were significantly lower in the DNK group compared to the conventional group at T3 and T4 (p<0.001). No significant difference was found in inotrope requirements after CPB (DNK: 32%; Conventional: 34%; p=0.64). Conclusion: Del Nido cardioplegia was associated with lower intraoperative lactate accumulation in adult CABG surgeries. This suggests that DNK provides more effective cellular oxygenation and maintains metabolic balance. In terms of myocardial functional protection, both cardioplegias are equally effective. DNK can be considered a noteworthy alternative in adult cardiac surgery due to its practical applicability, single-dose advantage, and safety.

Keywords

References

  1. Hausenloy DJ, Yellon DM. Cardioprotection during cardiac surgery: A review. Eur Heart J. 2017;38(47):3413–20.
  2. Del Nido PJ. Intermittent versus continuous cardioplegia. J Thorac Cardiovasc Surg. 1995;109(2):357–68.
  3. Mishra P, Ali A, Cannata A, et al. Del Nido cardioplegia in adults: A comprehensive review. J Card Surg. 2021;36(12):4345–53.
  4. Barbier R, Bical OM, Demondion P, et al. Efficacy of Del Nido cardioplegia in adult cardiac surgery. Ann Thorac Surg. 2020;110(4):1207–14.
  5. Westerhof N, Lamberts RR, Westerhof BE. Clinical advantages of single-dose Del Nido cardioplegia. Perfusion. 2019;34(4):273–80.
  6. Maillet JM, Le Besnerais P, Cantoni M, et al. Serum lactate after cardiac surgery and outcome. Ann Thorac Surg. 2003;75(6):1901–5.
  7. Rao V, Ivanov J, Weisel RD, et al. Metabolic benefits of Del Nido cardioplegia in adult CABG. J Cardiothorac Surg. 2018;13:71.
  8. Lee JH, Kim JB, Jung SH, et al. Myocardial protection and metabolic preservation with Del Nido solution. Interact Cardiovasc Thorac Surg. 2019;29(3):391–8.

Details

Primary Language

Turkish

Subjects

Surgery (Other)

Journal Section

Research Article

Publication Date

March 9, 2026

Submission Date

November 16, 2025

Acceptance Date

December 16, 2025

Published in Issue

Year 1970 Volume: 65 Number: 1

Vancouver
1.Özden Vezir. Metabolic effect of del nido cardioplegia in ısolated adult coronary artery bypass surgery: A retrospective comparative study. EJM. 2026 Mar. 1;65(1):209-13. doi:10.19161/etd.1824965

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.